I do not understand the investor relations of this company. We keep getting what looks like excellent traction in the US market, but all announcements are not market sensitive which assumes not high value contracts. They never disclose the potential revenue of these deals or any hope of turning a profit. Time to get this company to start selling themselves.
Ann: First Patients Enrolled at Allergy Partners in the US, page-4
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.65M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33770 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 341720 | 1 |
View Market Depth
| Last trade - 11.16am 10/07/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable